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Inversion polymorphisms between low-copy repeats (LCRs) might predispose chromosomes to meiotic non-allelic homologous recom-
bination (NAHR) events and thus lead to genomic disorders. However, for the 22q11.2 deletion syndrome (22q11.2DS), the most com-
mon genomic disorder, no such inversions have been uncovered as of yet. Using fiber-FISH, we demonstrate that parents transmitting
the de novo 3 Mb LCR22A–D 22q11.2 deletion, the reciprocal duplication, and the smaller 1.5 Mb LCR22A–B 22q11.2 deletion carry
inversions of LCR22B–D or LCR22C–D. Hence, the inversions predispose chromosome 22q11.2 to meiotic rearrangements and increase
the individual risk for transmitting rearrangements. Interestingly, the inversions are nested or flanking rather than coinciding with the
deletion or duplication sizes. This finding raises the possibility that inversions are a prerequisite not only for 22q11.2 rearrangements but
also for all NAHR-mediated genomic disorders.De novo 22q11.2 deletions (MIM: 192430) occur with an
estimated frequency of 1/3,000–1/6,000 live births1,2 and
1/1,000 pregnancies.3 Major clinical findings include
palatal abnormalities; immunodeficiency; hypocalcemia;
congenital heart disease; gastrointestinal, renal, and skel-
etal problems; mild dysmorphic features; developmental
delays; and learning and behavioral difficulties including
ADHD, anxiety disorders, autism, and psychotic illnesses,
such as schizophrenia.4–6 The 22q11.21 region contains
four LCRs associated with the condition; these are termed
LCR22A, LCR22B, LCR22C, and LCR22D.7,8 Individual
LCR22s show a heterogeneous architecture comprised of
many repeat subunits9–11 (Figure S1). The paralogous
sequences show similarity of up to 99.6%, driving meiotic
NAHR.12,13 LCR22A and LCR22D have the most complex
organization and flank the typical 3 Mb deletion
observed in 90% of individuals.8,14In the remaining
individuals, smaller nested deletions are observed.15
Reciprocal duplications are the meiotic NAHR comple-
ment and are causal for the 22q11.2 duplication syn-
drome (MIM: 608363).16 Inversion polymorphisms in
the genome might make NAHR more likely and have
been demonstrated to exist between flanking LCRs for
many genomic disorders, including Williams-Beuren
(7q11.23, MIM: 194050), Prader Willi/Angelman
(15q11-q13, MIM: 176270), 17q21.31 microdeletion
(MIM: 610443), and 8p23.1 microdeletion (MIM:
222400) syndromes.17–20 Not surprisingly, we and others
have searched for the existence of an inversion polymor-
phism in 22q11.2. Because inversion sizes underlying
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 2017sizes, interphase FISH experiments were performed within
and flanking the LCR22A–D interval in parents of individ-
uals with de novo 3 Mb 22q11.2 deletions. No inversion
polymorphism between LCR22A and LCR22D could be
identified.21,22
Scrutinizing the LCR22 subunit organization in the
reference genome showed the potential presence of paral-
ogous sequences of inverted, duplicated subunits.23 These
make the existence of inversions possible.24 In addition,
we applied the algorithm InveRsion25 to SNP data from
the 1000 genomes26 population to predict and determine
the global distribution of the inverted allele on the basis
of reduced recombination patterns. Variants with a MAF
below 0.1 were discarded, and window sizes ranged from
0.2 to 3 Mb by 0.2 Mb steps. We then usued InvClust to
predict haplotypic signatures induced by putative inver-
sions.27 Multidimensional scaling analysis was targeted
to genotypes between LCR22B and LCR22D and between
LCR22C and LCR22D. We kept the first two eigen-compo-
nents and used a mixture-model classification with the
invClust algorithm. We assigned inversion genotypes to
each cluster whenever the clustering confidence for each
sample was greater than 99%. We detected several positive
signals (BIC > 0) of LD differences at 0.2–3Mb window
sizes. The most significant of those signals corresponds to
the 0.4 Mb segment flanked by LCR22C and LCR22D.
This suggests the existence of a nested inversion polymor-
phism between LCR22C and LCR22D (Figure S2). In addi-
tion, several approaches to mapping inversions genome-
wide have been developed.28–30 On the basis of mapping
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Figure 1. Design and Fluorescence Patterns
(A) First probe design aligned with schematic representation of the LCR22B-D region. LCR22s are depicted with the Segmental Dups
track10,33in UCSC.34 Locations of known segmental duplications between LCR22B, LCR22C, and LCR22D are shown as connecting,
colored lines. Red and green oligos (hg19, chr22:21,104,802–21,311,933 and chr22:21,223,781–21,424,739) partially label the unique
sequence proximally from LCR22D and have 50 Kb of overlapping sequence depicted by the central yellow bar. A reference probe distal
to LCR22D (chr22:21,931,955–22,124,705) is labeled with a green-red mix, shown as a yellow bar. Oligos hybridized to a reference allele
show the expected wild-type (WT) sequence of red, overlapping yellow, and green signal strings. Subsequently, an unlabeled gap marks
the position of LCR22D, followed by the mixed reference signal. Inversion (INV) signals show a signal sequence of green, overlapping
yellow, and red, followed by the LCR22D gap and the mixed reference probe.
(B) Second probe design aligned with the LCR22B-D region. An additional green probe, starting proximally from LCR22C to the middle
of the repeat (chr22:20,499,302–20,699,303), is added. From this location, a red (chr22:20,699,530–20,899,531) and a green
(chr22:20,890,041–21,103,073) probe are designed to consecutively label 200 Kb each. A red reference probe marks the region distal
to LCR22D (chr22:21,572,091–21,773,001). Probe patterns suggest a LCR22C–D inversion polymorphism.
(C) A probe pattern suggesting a LCR22B–D inversion.predicted between LCR22B and LCR22D in three out of
nine individuals (invFEST database).31
To ascertain the validity of these predictions, we
designed a fiber-FISH assay and applied it on immortalized
EBV-transformed lymphoblastoid cell lines derived from
peripheral blood samples.32 To detect potential inversions
proximal to LCR22D, we designed three fluorescently
labeled oligonucleotide probes flanking the LCR (Figure 1).
The probes were labeled with red (Cy3), green (FITC), and a
mix of both, generating a yellow signal (Agilent Technolo-
gies, California, USA). Fibers were counterstained with
DAPI.The AmericaDNA fibers were stretched as previously described.35
Visualization was performed with an epifluoresence micro-
scope (Zeiss Axioplan) at 6003magnification. Using Cyto-
vision (Leica Biosystems, Nussloch), we recorded signals if
(1) all three or four fluorescent signal strings were ordered
in a consecutive and linear way, (2) distances between
signal strings were concordant with the design, if LCR vari-
ability was taken into account, and (3) local fiber density
was low, such that the chance of detecting ‘‘hybrid’’ signals
from different fibers was reduced. Hybridization of this
pattern on a control cell line (GM19238) resulted in ten
fibers with the predicted wild-type pattern in the order ofn Journal of Human Genetics 101, 616–622, October 5, 2017 617
red, green, and yellow (Figure 1A). In addition, one fiber
had an inversion signal in the order green, red, and yellow
(Figure 1A). LCR22D can be seen as a gap in the string
between the green and yellow signals (Figure 1A). To deter-
mine the frequency of false-positive signals for an inver-
sion, we used the assay to screen two hydatidiform mole
hTERT-immortalized cell lines (CHM1 and CHM13). These
hydatidiform molar cell lines are haploid. Hence, either all
or none of the fibers should be inverted. 1/20 (5%) and
4/23 (17.39%) of the fiber patterns presented inverted
alleles in the CH1 and CHM13 cell lines, respectively.
Because the moles are presumably wild-type, we conse-
quently defined cells with less than 20% inverted signals
to be wild-type and cells with more than 20% inverted
signals to have the inversion.
Because our a priori assumption was that an inversion in
a parent would predispose a child to having a 22q11.2 dele-
tion, we initially performed the assay on family 1 (Table
S1). Both parents are unaffected and have a child with a
de novo 22q11.2 deletion. Fiber-FISH showed that one of
the parents in family 1 had two different patterns: the
wild-type pattern and the pattern indicative for an inver-
sion proximal to LCR22D (Figure 1A). On DNA fibers
from the other parent, only the wild-type pattern was
observed. Short tandem-repeat polymorphism analysis of
both parents and a sibling demonstrated that the
22q11.2 deletion was derived from chromosome 22 of
the parent carrying the inversion.
To confirm that this inversion polymorphismwould pre-
dispose a parent to having a child with a de novo 22q11.2
rearrangement, we recruited an additional 16 trios. All
individuals in the study were informed of the project’s out-
lines and gave written consent for their EBV cell lines and
DNA to be used for sequencing and genotyping purposes.
The study was approved by the medical ethics committee
of the University hospital of Katholieke Universiteit
Leuven. The research study subjects had been diagnosed
on the basis of a clinical examination and molecular
testing, by FISH with N25 probe or with TUPLE1 and
ARSA probes (Abbot Molecular), by Illumina HumanCyto-
SNP-12 V2.1 BeadChip analysis, or by analysis with the
MLPA SALSA P250 DiGeorge diagnostic probe kit (MRC-
Holland).
All probands had a de novo 22q11.2 rearrangement,
whereas their parents were unaffected. Fifteen probands
carried the most common 3 Mb LCR22A–D deletion. One
other proband carried the 1.5 Mb LCR22A–B deletion,
and an additional proband had an LCR22A-D duplication
(Table S1). To determine the parents-of-origin of the
22q11.2 deletions, we amplified four microsatellites in
the deleted region and two outside. All marker sizes were
compared visually for trios, and the parent-of-origin was
determined. At least three STRs were informative in every
family, and paternity was confirmed for all (data not
shown).
Lymphoblastoid cell lines of all parents were screened
for the presence or absence of an inversion. In one618 The American Journal of Human Genetics 101, 616–622, Octobeparent-of-origin only, the regular string of FISH signals
was observed indicating that this parent matched the
homozygous reference structure, whereas the remaining
sixteen parents-of-origin were carriers of an inverted allele
(94.1%). To confirm the fiber-FISH findings, we also per-
formed interphase FISH on a subset of cells derived from
twelve individuals (Figure S3). In the six individuals fiber-
FISH suggested to be wild-type, inversion signals were
observed in 10%–15% of nuclei. A small percentage of
apparent inversions is expected as a result of chromatin
folding. In all seven individuals suggested to be heterozy-
gous for the inversion by fiber-FISH, interphase inversion
signals were observed in 36%–47% of the nuclei. Because
this is significantly higher than the percentage in wild-
types, we conclude that the interphase results are concor-
dant with the fiber-FISH data (Table S1).
Because 16 out of 17 parents-of-origin carry an inver-
sion, it is highly likely that the inversion is a risk factor
for 22q11.2 rearrangements. Surprisingly, the inversion
was also detected in eight out of 17 non-transmitting
parents (47.1%) who had passed the intact chromosome
22 to the affected child (Table S1). This observation sug-
gested that the inversion is a common polymorphism in
the population.
To determine the population frequency, we screened 11
additional individuals (Table S1). Seven random EBV cell
lines established during unrelated routine tests by the
hospital were used as normal population controls. Three
additional HapMap control cell lines (Coriell Cell Reposi-
tory) were randomly picked from those available in the
lab and cultured according to standard protocols.
Out of the 13 controls, 11 random individuals and the
two haploid cell lines, five were detected as heterozygous
(38.5%), a proportion similar to the occurrence of the
inversion in the non-transmitting parent. When com-
bined with the parental ratios, the population incidence
of the inversion allele is 45%. In contrast, the incidence
of the inversion in the parent-of-origin for the children
affected with the 22q11.2 deletion or duplication is 94%
(Figure 2). This is significantly higher than the occurrence
in the general population (Fisher exact p¼ 0.0012). Hence,
the 22q11.2 inversion polymorphism makes NAHR events
on chromosome 22q11.2 more likely. The population inci-
dence of 22q11DS is about 1/3,000. If we assume that the
inversion is a prerequisite for NAHR, the deletion should
only occur in inversion carriers, which make up 47.9% of
the population. As a consequence, the individual risk for
an inversion carrier is about twice the population inci-
dence. Thus, a parent that is a carrier of an inversion has
an estimated chance of 1/1,350 of having a child with
22q11DS. A variable frequency of the inversion allele
might also underlie differences in the 22q11DS frequency
among populations.36
We hypothesized that the inversions observed in the
fiber-FISH probe pattern could be the result of both
LCR22C–D and LCR22B–D inversions. To specify which
of these rearrangements occurs, we designed a secondr 5, 2017
Figure 2. Genotype Distributions in Parents-of-Origin, the Non-
transmitting parents, a Population Sample, and Eight Individuals
Whose Parents Are Both Carriers of an Inversion Polymorphism
No individuals homozygous for the inversion were detected, nor
did any of the individuals carry a remaining allele with an
inversion.probe set containing an additional green-labeled oligonu-
cleotide probe in the region between LCR22B and
LCR22C. Red and green probes were extended in compar-
ison to the first pattern, and the reference probe distal to
LCR22D was only labeled red. The proximal green and
red probes were designed so that they would both extend
to the middle of LCR22C. Thirteen normal individuals
were tested with the new probes. Three carried inversions
between LCR22C and LCR22D, and 10 carried them
between LCR22B and LCR22D (Figures 1B and 1C and
Table S1).
Now, 22q11.2DS can be added to the growing list of
genomic disorders triggered by the presence of inversions.
For the 5q35 deletion in Sotos syndrome (MIM: 117550),
the 8p23 rearrangements, and the 17q21.31 deletions
and duplications, all parents-of-origin are carriers of an
inversion polymorphism between flanking LCRs.19,37,38
For these syndromes, the parental inversion is thought to
be an obligate prerequisite that triggers these rearrange-
ments. On the other hand, in Williams-Beuren syndrome
and the Prader-Willi and Angelman syndromes, respec-
tively, 30% and 66% of parents-of-origin carry an inversion
polymorphism.17,18,39 The inversion is considered a sus-
ceptibility factor. However, whereas inversions in these
genomic disorders are larger or of similar size to the region
of deletion or duplication, we demonstrate here that
22q11.2 inversions are nested in or even flanking the larger
rearrangements for which they cause a predisposition.
Perhaps also all parents-of-origin of the Williams-BeurenThe Americasyndrome and the Prader-Willi and Angelman syndromes
carry nested or flanking small inversion polymorphisms
that remain undetected. In theWilliams-Beuren syndrome
region, three LCRs are present. One third of Williams-Beu-
ren syndrome parents-of-origin have a 1.79 Mb to 2.56 Mb
proximal-distal inversion that predisposes them to having
a child with the most-common 1.55 Mb proximal-medial
LCR deletions.40 Interestingly, two additional small inver-
sion polymorphisms have been reported between the
medial and distal LCRs. These are hypothesized to increase
susceptibility to nested deletions in the distal LCRs.41 The
potential existence of these inversions in parents-of-origin
has not yet been investigated.
Two mechanisms have been invoked to explain how
inversions trigger NAHR. An inversion can lead to unstable
asynaptic bubbles during meiosis; these bubbles are prone
to breaks and secondary rearrangements.42 Alternatively,
the inversion could re-orient the paralogous subunits
from being in opposing to be in identical direction.
NAHR of subunits in opposing orientation would result
in an inversion, whereas NAHR of subunits in an identical
orientation would generate deletions or duplications. In
addition, the inversion could cause paralogous sequences
to be more equally spread among LCRs, resulting in longer
stretches of similarity and hence a higher chance for non-
allelic homologous pairing and recombination. Thus, the
risk of NAHR might increase between different LCR22s de-
pending on the exact position of the inversion breakpoints
within the LCRs. Because all but one of the parents-of-
origin carry an inversion, we speculate that the inversion
polymorphisms might be a necessary prerequisite to any
of the known 22q11.2 rearrangements. In the one
parent-of-origin without an inversion of LCR22B–D, we
speculate that there might be another structural variation,
proximal or distal to the LCR22B–D interval.
Surprisingly, no individuals homozygous or hemizygous
for the inversion were observed. If the 29 diploid popula-
tion samples and non-transmitting parents were in
Hardy-Weinberg equilibrium, at least one individual
should be homozygous for the inversion (chi-square test:
p ¼ 0.1198). Additionally, in eight individuals for whom
both parents are inversion carriers, none carried the inver-
sion (p ¼ 0.0039). One possible explanation could be that
the inversion breakpoints alter or disrupt the function or
regulation of one or multiple essential genes. LCR22s
contain four known genes, USP18 (Ubiquitin Specific
Peptidase 18,MIM: 607057),GGT (GammaGlutamyltrans-
peptidase, MIM: 612346), GGT5 (Gamma Glutamyltrans-
ferase 5, MIM: 137168) and BCR (Breakpoint Cluster
Region, MIM: 151410). Each has been (partially) dupli-
cated during primate evolution and transposed on
22q11.2 to create a mosaic of largely pseudogenes.11 Addi-
tionally, inversion polymorphisms are known to affect
topological associations between functional genes and
their regulating elements, leading to more-distant ef-
fects.43–48 For several other genomic disorders, it has
been demonstrated that genes within LCRs can modulaten Journal of Human Genetics 101, 616–622, October 5, 2017 619
neurodevelopmental phenotypes.49,50 In analogy, a similar
phenomenon might take place at 22q11. Negative selec-
tion for inversion homozygotes during embryogenesis
might explain the observed difference between the inci-
dence of the 22q11DS in fetuses in low-risk women
without evidence of congenital heart disease or palatal
anomalies on ultrasound (1/1000)3,51 and the popula-
tion incidence of 1/3000–1/6000 live births. On the other
hand, negative selection of inversion homozygotes is in
contradiction with the high frequency of heterozygotes.
Another explanation would be that the population
sampled is too small. Larger population studies and better
mapping of the inversion polymorphisms are required to
confirm this observation.Supplemental Data
Supplemental Data contain three figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
2017.09.002.Consortia
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